Media Contact:Alison Guzzio484-459-3243Alison.guzzio@thirdlaw.tech Philadelphia, PA – May 7, 2025 – ThirdLaw Molecular Inc., a pioneering drug discovery company, today announced that DJ Bernsteel, PhD, will present groundbreaking research on screening a 4.5...

Media Contact: Alison Guzzio 484-459-3243 Alison.guzzio@thirdlaw.tech ThirdLaw Molecular has pioneered the development of Spiroligomer™ molecules – an entirely new, synthetic, therapeutic modality that reimagines molecular therapeutics  Spiroligomer™ molecules combine...

Award winning medicinal chemist, Dr. Joseph Vacca, joins Third Law Molecular LLC as Scientific Advisor, bringing deep drug discovery and development experience, to advance its groundbreaking new platform for targeted drug discovery. Joins Dr. Tomi Sawyer, Peptide Drug...